Guarini A - Search Results

1

Optimizing Molecular Minimal Residual Disease Analysis in Adult Acute Lymphoblastic Leukemia.

Della Starza I, De Novi LA, Elia L, Bellomarino V, Beldinanzi M, Soscia R, Cardinali D, Chiaretti S, Guarini A, Foà R. Della Starza I, et al. Among authors: guarini a. Cancers (Basel). 2023 Jan 6;15(2):374. doi: 10.3390/cancers15020374. Cancers (Basel). 2023. PMID: 36672325 Free PMC article. Review.

2

Has IL2 a role in the management of minimal residual disease for acute leukemia?

Foa R, Meloni G, Guarini A, Mandelli F, Gavosto F. Foa R, et al. Among authors: guarini a. Leukemia. 1992 Nov;6 Suppl 4:92-4. Leukemia. 1992. PMID: 1434844 Review.

3

IL2 treatment for cancer: from biology to gene therapy.

Foa R, Guarini A, Gansbacher B. Foa R, et al. Among authors: guarini a. Br J Cancer. 1992 Dec;66(6):992-8. doi: 10.1038/bjc.1992.400. Br J Cancer. 1992. PMID: 1457368 Free PMC article. Review.

4

Autologous bone marrow transplantation followed by interleukin-2 in children with advanced leukemia: a pilot study.

Meloni G, Foà R, Tosti S, Vignetti M, Mancini F, Guarini A, Marchis D, Gavosto F, Mandelli F. Meloni G, et al. Among authors: guarini a. Leukemia. 1992 Aug;6(8):780-5. Leukemia. 1992. PMID: 1640729

5

Defective lymphokine-activated killer cell generation and activity in acute leukemia patients with active disease.

Foa R, Fierro MT, Cesano A, Guarini A, Bonferroni M, Raspadori D, Miniero R, Lauria F, Gavosto F. Foa R, et al. Among authors: guarini a. Blood. 1991 Aug 15;78(4):1041-6. Blood. 1991. PMID: 1868239 Free article.

6

Interleukin-2 may induce prolonged remissions in advanced acute myelogenous leukemia.

Meloni G, Foa R, Vignetti M, Guarini A, Fenu S, Tosti S, Tos AG, Mandelli F. Meloni G, et al. Among authors: guarini a. Blood. 1994 Oct 1;84(7):2158-63. Blood. 1994. PMID: 7919330 Free article. Clinical Trial.

7

Interleukin-2-based immunotherapy in the management of minimal residual disease in acute leukemia patients.

Foa R, Meloni G, Guarini A, Vignetti M, Marchis D, Tosti S, Gillio Tos A, Mandelli F, Gavosto F. Foa R, et al. Among authors: guarini a. Recent Results Cancer Res. 1993;131:207-14. doi: 10.1007/978-3-642-84895-7_18. Recent Results Cancer Res. 1993. PMID: 8210640 No abstract available.

8

Cytotoxic effectors activated by low-dose IL-2 plus IL-12 lyse IL-2-resistant autologous acute myeloid leukaemia blasts.

Vitale A, Guarini A, Latagliata R, Cignetti A, Foa R. Vitale A, et al. Among authors: guarini a. Br J Haematol. 1998 Apr;101(1):150-7. doi: 10.1046/j.1365-2141.1998.00645.x. Br J Haematol. 1998. PMID: 9576195 Free article.

9

Microsatellite analysis in childhood acute lymphoblastic leukemia.

Reato G, Basso G, Putti MC, Cignetti A, Guarini A, Foa R. Reato G, et al. Among authors: guarini a. Haematologica. 1998 May;83(5):403-7. Haematologica. 1998. PMID: 9658723 Clinical Trial.

10

Interleukin-2 gene transfer into human transitional cell carcinoma of the urinary bladder.

Milella M, Jacobelli J, Cavallo F, Guarini A, Velotti F, Frati L, Foà R, Forni G, Santoni A. Milella M, et al. Among authors: guarini a. Br J Cancer. 1999 Feb;79(5-6):770-9. doi: 10.1038/sj.bjc.6690124. Br J Cancer. 1999. PMID: 10070868 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

454 results

Search Page

Filters